Synthesis and application of new chiral amines in Dutch resolution:Family Behaviour in Nucleation Inhibition. by Dalmolen, Jan
  
 University of Groningen
Synthesis and application of new chiral amines in Dutch resolution
Dalmolen, Jan
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2005
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Dalmolen, J. (2005). Synthesis and application of new chiral amines in Dutch resolution: Family Behaviour
in Nucleation Inhibition. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
   
 







Non-reductive Removal of the (R)-




In this chapter the syntheses of enantiopure (R)-1-aryl-3-butenylamines and (R)-1-aryl-1-
butylamines are described. The unsaturated 1-aryl-3-butenylamines can be synthesized via 
a non-reductive removal of the PGA chiral auxiliary from the PGA homoallylamines 
described in Chapter 3. This method provides a broad range of chiral 1-aryl-3-
butenylamines in high enantiomeric purity, which can be valuable synthons in the 
preparation of biologically active compounds or can be used in Dutch Resolution 
experiments. The saturated (R)-1-aryl-1-butylamines can be obtained by a mild reduction 
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4.1   Introduction 
Enantiomerically pure homoallylamines are valuable synthons for the preparation of 
biologically active compounds such as β-amino acids or esters, 1,3-amino alcohols, and    
1-amino-3,4-epoxides as illustrated in Figure 4.1.[1,2] For instance, the application of       

























Figure 4.1 Conversion of protected homoallylamines into topically interesting compounds.  
 
Recently, homoallylamines proved to be key building blocks for the preparation of 

































Scheme 4.1. Synthesis of 4.2[3] and 4.4[4] via a ring closing metathesis. 
4.2   Non-reductive Removal of the Chiral Auxiliary 
Because the reductive removal of the chiral auxiliary as described in Chapter 3 failed for 
some of the adducts, we sought alternative routes for the conversion of the phenylacetamide 
protected homoallylamines into the desired “free” (R)-1-aryl-1-butylamines. In a general 
procedure, the (R)-PGA homoallylamines 3.42–3.59 are converted into N-benzylidene 
protected homoallylamines 4.23–4.40 by “retro-Strecker” methodology as shown 



















Scheme 4.2 Retro-Strecker synthesis of N-benzylidene protected homoallylamines          
(R)-4.23–4.40. Reagents and conditions: (a) Vilsmeier reagent ([ClCH=N(CH3)2+Cl-],     
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Halo-, phenyl-, nitro-, hydroxy- and naphthyl-substituted PGA allylamines have been 
subjected to this non-reductive deprotection procedure as reported recently.[5c] 
 
The conversion of the PGA protected allylamines (R,R)-3.42–3.59 into nitriles 4.5–4.22 is 
based on dehydration of the amide moiety with preformed Vilsmeier reagent 
[ClCH=N(CH3)2+Cl-] [6] in combination with one equivalent of triethylamine. In a general 
procedure, the Vilsmeier reagent is formed in situ by reaction of DMF with oxalyl chloride 
in CH2Cl2 at 0 oC. A solution of the amide in CH2Cl2 is then added to the Vilsmeier reagent. 
The addition of 1 equivalent of an organic base such as triethylamine drives the formation 
of the nitrile to completion. Table 4.1 summarizes the results of the formation of the 
corresponding nitriles.  
 
Although the stereocenter of the chiral auxiliary partially epimerizes under these 
conditions, the deprotection proceeds with full retention of configuration at the homoallylic 
stereocenter as revealed by the fact that enantiomerically pure amines are obtained after 
complete deprotection (Table 4.2, entries 2–7). Although under these conditions the 
stereocenters of the chiral auxiliary moiety are partially epimerized in nitriles 4.5–4.14, 
4.21 and 4.22, the deprotection proceeds with full retention of configuration at the 
homoallylic stereocenter as revealed by the fact that enantiomerically pure amines are 
obtained after complete deprotection (Table 4.2, entries 2–7). 
 
The non-reductive removal failed for nitro-substituted substrates 3.52–3.54, probably 
because of the sensitive nature of the NO2-group (Table 4.1, entries 11–13). A complex 
mixture of products, including starting material, was observed by NMR spectroscopy.  
 
Treatment of hydroxy-substituted PGA homoallylamines 3.55–3.57 (entries 14–16) with 
1.5 equivalents of Vilsmeier reagent also failed to produce the corresponding nitriles 4.18–
4.20. The failure of this reaction is probably due to the relatively acidic phenolic hydroxyl 
group. Addition of more than one equivalent of triethylamine failed to lead to formation of 
the desired nitriles. In all cases complex mixtures of products were obtained. 
 
The conversion of nitriles 4.5–4.22 into the N-benzylidene protected allylamines (R)-4.23–
4.40 involves the elimination of HCN. Treatment of the crude nitrile with two equivalents 
of K2CO3 for two hours in refluxing ethanol results in full elimination of HCN, providing 
the benzylidenes in high yields (Scheme 4.2 and Table 4.1). Acidic hydrolysis is usually the 
method of choice for the deprotection of benzylidene protected amines.[7] To our surprise, 
these benzylidenes are rather stable in aqueous HCl at ambient temperatures. At elevated 
temperatures, the benzylidenes are hydrolyzed although aza-Cope rearrangement is a 
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Table 4.1 Formation of nitriles 4.5–4.22 by dehydration of the (R)-PGA-moiety and 
formation of (R)-N-benzylidenes 4.23–4.40 by elimination of HCN. 
Entry Allylamine Ar Nitrile Yield (%)[a] Benzylidene Yield (%)[a] 
1 3.42 C6H5 4.5 95 4.23 86 
2 3.43 o-Cl C6H4 4.6 87 4.24 78 
3 3.44 m-Cl C6H4 4.7 87 4.25 85 
4 3.45 p-Cl C6H4 4.8 99 4.26 86 
5 3.46 o-Br C6H4 4.9 81 4.27 75 
6 3.47 m-Br C6H4 4.10 92 4.28 >99 
7 3.48 p-Br C6H4 4.11 83 4.29 >99 
8 3.49 o-Ph C6H4 4.12 89 4.30 70 
9 3.50 m-Ph C6H4 4.13 78 4.31 69 
10 3.51 p-Ph C6H4 4.14 80 4.32 79 
11 3.52 o-NO2 C6H4 4.15 – [b] 4.33 – 
12 3.53 m- NO2 C6H4 4.16 – [b] 4.34 – 
13 3.54 p- NO2 C6H4 4.17 – [b] 4.35 – 
14 3.55 o-OH C6H4 4.18 – [c] 4.36 – 
15 3.56 m-OH C6H4 4.19 – [c] 4.37 – 
16 3.57 p-OH C6H4 4.20 – [c] 4.38 – 
17 3.58 1-Naphthyl 4.21 80 4.39 95 
18 3.59 2-Naphthyl 4.22 80 4.40 94 
[a] Isolated yield. [b] Mixture of compounds, including starting material. [c] Complex mixture 






















Scheme 4.3 Competing aza-Cope rearrangement at elevated temperatures.[8] 
 
Hydroxylamine hydrochloride in aqueous THF [9] proved to be the reagent of choice for the 
room temperature hydrolysis of the N-benzylidene protected arylbutenylamines               
(R)-4.23–4.40 (Scheme 4.4), which provided the 1-aryl-3-butenylamines (R)-4.41–4.52 in 
yields up to 80 % (Table 4.2). 
 
Scheme 4.4 and Table 4.2 Synthesis of 4.53–4.62 by hydrolysis followed by reduction of 




























1 4.23 C6H5 4.41 80 3.64 nd nd 
2 4.24 o-Cl C6H4 4.42 75 4.53 91 >99:1 
3 4.25 m-Cl C6H4 4.43 58 4.54 >99 >99:1 























5 4.27 o-Br C6H4 4.45 65 4.56 99 >99:1 
6 4.28 m-Br C6H4 4.46 51 4.57 >99 >99:1 
7 4.29 p-Br C6H4 4.47 48 4.58 85 >99:1 
8 4.30 o-Ph C6H4 4.48 57 3.74 nd nd 
9 4.31 m-Ph C6H4 4.49 45 4.59 93 nd 
10 4.32 p-Ph C6H4 4.50 49 4.60 95 nd 
11 4.39 1-naphthyl 4.51 60 4.61 >99 nd 
12 4.40 2-naphthyl 4.52 47 4.62 >99 nd 
[a] Isolated yield. [b] Analysis by HPLC.[10] nd: Not determined. 
As the allylic moiety is preserved in this non-reductive procedure, valuable 
homoallylamines like 4.41–4.52 could be obtained in overall yields up to 65 % (3 steps). 
An example of the synthetic value of this methodology is the synthesis of (R)-1-para-
bromophenyl-3-butylenamine 4.47. This chiral homoallylamine is a useful building block in 












(R)-4.47 4.63  
 
With satisfactory results for the synthesis of the arylbutenylamines (R)-4.41–4.52 in hand, 
we undertook further reduction of the double bond by catalytic hydrogenation with H2 in 
the presence of 5 % platinum on carbon,[12] which gave the corresponding saturated 
substituted 1-arylbutylamines (R)-4.53–4.62 in almost quantitative yields (Scheme 4.2, 
Table 4.2). Samples were taken during the reaction and analyzed by 1H- and 13C-NMR to 
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case of reduction of the bromo-substituted phenylbutenylamines (R)-4.45–4.47 (entries 5–
7) high yields of the saturated butylamines 4.56–4.58 were obtained. The loss of the bromo-
substituents has not been observed if the hydrogenation time was limited to one hour at 
ambient temperature. However, longer reaction times also resulted in a considerable 
amount of the dehalogenated products. 
 
The undesired dehalogenation in the reductive removal of the chiral auxiliary, as described 
in Chapter 3 (section 3.2.2), can be used to our advantage. For ee-determination by HPLC 
analysis, the chloro- and bromo-substituted 1-aryl-3-butylamines 4.53–4.58 were all 
dehalogenated into 1-phenyl-1-butylamine 3.64 with H2 and 10 % palladium on carbon in 
EtOAc (Scheme 4.5). The high enantiomeric ratios (er) of these chiral amines (Table 4.2, 
entries 2–7) determined by this general HPLC method again confirmed the 
diastereoselectivity of the allylation reaction and lack of racemization of the phenylglycine 
amide moiety. 
 










Scheme 4.5 Dehalogenation and reduction of 4.53–4.58 into 3.64 for ee-determination by 
HPLC analysis. 
4.3   Synthesis of Nitro-substituted Phenylbutylamines 
Owing to the failure of both reductive as non-reductive removal towards the nitro-
substituted phenylbutylamines an alternative method was examined. Nitration of 
enantiomerically pure 1-phenyl-1-butylamine (R)-3.64 with nitric acid[13] provided a 
mixture containing (R)-1-ortho-nitrophenyl-1-butylamine [(R)-4.64] and (R)-1-para-
nitrophenyl-1-butylamine [(R)-4.65] in a ratio of 22:78 (Scheme 4.6). This mixture of 
regio-isomers was used without further separation. 
 
The meta-nitro-substituted 1-phenyl-1-butylamine (R)-4.69 was prepared starting from 
commercially available butyrophenone 4.66 (Scheme 4.7). The m-nitrobutyrophenone 4.67 
was obtained by nitration of butyrophenone 4.66 with HNO3 (85 %).[14] The best yield of 


























Scheme 4.6 Nitration of enantiopure (R)-1-phenyl-1-butylamine 3.64. Reagents and 
conditions: HNO3 (85 %), –5 °C, 4h. 
 
The main product was the meta-nitro-compound, which is generally accompanied by a 
small and variable amount of the ortho-isomer. The meta-nitro compound is easily 
separated from this mixture by crystallization and obtained pure in 55 % isolated yield. 
Subsequently, primary amine 4.69 was synthesized by a Leuckart reductive amination of 
4.67, followed by resolution of racemic 4.69 (section 4.4 of this chapter). In the first step of 
the Leuckart reaction, the imine is formed in situ with formamide (HCONH2) followed by a 
reduction with formic acid. The obtained formamide 4.68 is subsequently hydrolyzed with 


















Scheme 4.7 Reagents and conditions: (a) HNO3 (85 %), –5 °C, 4h ; (b) HCONH2/HCO2H, 
∆; (c) HCl, ∆; (d) (+)-Phencyphos 4.70/(+)-Nitrocyphos 4.73 (90:10), 2-butanone/H2O, ∆, 
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4.4   Dutch Resolution of Meta-nitro-phenylbutylamine 
Subsequently, the racemic meta-nitro-phenylbutylamine needed to be resolved. Several test 
experiments (1 mmol) were performed,[15] establishing that meta-nitro-phenylbutylamine 
4.69 could successfully be resolved with the cyclic phosphoric acid (S)-(+)-4.70, known by 
the trivial name of Phencyphos. The structures of Phencyphos and some of its family 
members are given in Figure 4.2.[16,17] Note that all (+)-enantiomers are homochiral; 
because of Cahn-Ingold-Prelog priority rules (CIP-rules) for the various aromatic 


































Figure 4.2 Family of structurally related cyclic phosphoric acids and their trivial 
names.[16] 
 
As the absolute configuration of the Phencyphos moiety was known, X-ray crystallographic 
analysis unambiguously showed that after resolution with (S)-(+)-4.70, the chiral center 




























Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
The resolution of racemic meta-nitro-phenylbutylamine 4.69 with (S)-(+)-Phencyphos in 
the absence of an additive delivered a first salt with a de value of 34 % and an S-factor[19] of 
0.30 (Table 4.3, entry 1). Under the same conditions, resolution with (+)-Chlocyphos as the 
parent resolving agent resulted in the precipitation of a salt with no diastereoselectivity 
(entry 2). In both cases, resolution experiments with either Anicyphos or Nitrocyphos failed 
to produce precipitated salts (entries 3 and 4). 
Table 4.3 Resolution of meta-nitro-phenylbutylamine 4.69 with one member of the cyclic 
phosphoric acid family 4.70–4.73 as the resolving agent. 
Entry Resolving 
Agent 





















































precipitates   
[a] 033 mmol·mL-1 in 2-butanone:H2O (2:1). [b] Isolated yield of the first salt.                       
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Several experiments were performed, analogous to the second generation Dutch Resolution 
experiments described by Nieuwenhuijzen et al.[20] The resolution process could be 
considerably improved on replacement of 10 mol % of (+)-Phencyphos by one of the 
structurally closely related family members depicted in Figure 4.2. On substitution by       
10 mol % of (+)-Chlocyphos 4.71, the de value increases from 34 % to 67 % (Table 4.4, 
entry 2). (+)-Chlocyphos 4.71 itself gave first salts with lower de’s. In the presence of 10 
mol % of (+)-Anicyphos 4.72 or (+)-Nitrocyphos 4.73, the de value of the first isolated salt 
increases to 78 % and 77 % respectively, and the S-factor increases to respectively 0.58 and 
0.59 (entries 3 and 4). 
 
Table 4.4 Resolution of meta-nitro-phenylbutylamine 4.69 in the presence of a family 


































































10 38 77 0.59 










Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
The amount of the additives 4.71-4.73 present in the salt could be readily determined by 
1H-NMR spectroscopy. Analysis of the 1H-NMR spectra in the region of 5.0–5.6 ppm 
revealed that the benzylic proton (indicated as a in Figure 4.5) of the Phencyphos part of 
the salt gives rise to a doublet at δ = 5.00 ppm, while the benzylic protons of the substituted 
cyclic phosphoric acids (indicated as a’) resonate typically at lower field (5.45–5.60 ppm). 
By comparing the integrals of both signals, the ratio could be determined. A practical 





















Figure 4.4 Example of determination of the amount of additive in the salt by 1H-NMR 
spectroscopy in the case of Anicyphos 4.72 as an additive. 
 
It was found that in the precipitation of the first salts, in the cases of Chlocyphos and 
Anicyphos, the additives were present in a smaller amount than the initial amounts started 
with (Table 4.5, entries 1 and 2). In the case of Nitrocyphos as a family member, no 
detectable amount of the additive was incorporated in the salt (entry 3).[21] 
 
Recrystallization of the mixed salts resulted in a shift in composition; after one 
recrystallization from i-propanol/H2O (2:1) (entries 1 and 2) a salt was obtained which only 
contained Phencyphos as the anionic counter-ion. No detectable amounts of the additives 
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Table 4.5 Amount of additive present in the salts in the resolution of 4.69. 
Entry Ar Amount in first 
isolated salt [a] 































0 % – 
[a] Determined by 1H-NMR. 
 
In large scale experiments (80 mmol), the resolution was performed in the presence of the 
non-incorporated Nitrocyphos. Since Nitrocyphos was not found in the first isolated salt, 
the parent resolving agent could be easily recycled. After one recrystallization of the first 
obtained salt from i-propanol/H2O (2:1) and liberation, the free amine (R)-4.69 was 
obtained in 24 % yield and > 99 % ee (limit of detection). 
4.5   Proposed Synthesis of Hydroxy-substituted Phenylbutylamines 
As mentioned earlier in this chapter, the conversion of the hydroxy substituted PGA 
allylamines 3.55–3.57 into nitriles 4.18–4.20 failed, probably due to the presence of the 
relatively acidic phenolic hydroxyl group. 
A plausible route to the desired hydroxy substituted phenylbutylamines is proposed in 
Scheme 4.8. In this strategy, O-benzyl protected imines 4.74–4.76 can be synthesized from 
the corresponding commercially available O-benzyl benzaldehydes. After 
diastereoselective allylation (step a), O-benzyl protected PGA allylamines 4.77–4.79 can be 










Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
(steps b–d), providing homoallylamines 4.80–4.82. Because in 4.78–4.79 the acidic 



























Scheme 4.8 Proposed synthetic route to the hydroxy-substituted 1-phenyl-1-butylamines 
4.83–4.85. (a) Diastereoselective allylation; (b–d) non-reductive removal of the PGA 
auxiliary; (e) O-debenzylation and reduction of the allylic moiety. 
 
It is well known in the literature that O-benzyl ether protecting groups are easily removed 
under hydrogenolysis conditions (H2/Pd-C); compounds 4.80–4.82 most probably will be 
no exception (step e).[7,22] Catalytic hydrogenolysis of O-benzyl protected homoallylamines 
4.80–4.82 would lead to catalytic debenzylation as well as the hydrogenation of the allylic 
moiety, providing the desired hydroxy-substituted 1-phenyl-1-butylamines 4.83–4.85. 
Removal of the benzyl ethers with sodium/ammonia might leave the double bond intact, 
yielding the unsaturated hydroxy substituted 1-phenyl-3-butenylamines.[23] We have not 
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4.6   Conclusions 
This chapter further illustrates the versatility of (R)-PGA allyl amines in the synthesis of 
topically interesting amines bearing a stereogenic center at the α–position. The chiral 
auxiliary is conveniently removed under either reductive- or non-reductive conditions.  
The problems we encountered with the reductive removal of the chiral auxiliary in the 
synthesis of the bromo-, chloro-substituted and naphthyl amines could be overcome. In the 
mild reduction of the 1-naphthyl-3-butenylamines with H2/Pt-C, no ring hydrogenation was 
observed. 
The high enantiomeric ratios (er) of 4.53–4.57 again confirm the high diastereoselectivities 
of the allylation reaction and lack of racemization of the phenylglycine amide moiety. 
The sensitivity of the hydroxy- and the nitro-group prevented the synthesis of the desired 
substituted phenylbutylamines using the reductive- or non-reductive removal of the chiral 
auxiliary. Alternative routes were used to synthesize the nitro-substituted 1-aryl-1-
butylamines. An alternative route has been proposed to synthesize the hydroxy substituted 
analogues. 
4.7   Experimental Section 
General information: For general remarks concerning all experimental details see 
experimental section in Chapter 3. 
Typical procedure for the formation of nitriles 4.23–4.40.[5c] To dichloromethane (450 
mL), cooled in an ice bath, was added dimethylformamide (48.8, mmol, 3.79 mL). Oxalyl 
chloride (48.8 mmol, 4.60 mL) was added dropwise. After the formation of gas (CO and 
CO2) had ceased, the (R,R)-PGA allylamine (32.5 mmol) dissolved in dichloromethane 
(100 mL ) was added all at once. Triethylamine (32.5 mmol, 4.60 mL) was added dropwise 
over 30 minutes and the reaction was stirred at room temperature for 30 minutes. Water 
(450 mL) was added and the organic phase was separated. The organic layer was dried over 
Na2SO4 and filtered. Evaporation of the solvent yielded the crude product, which was used 
without further purification.  
From the mixture of diastereomers, only the most abundant is described. 
 
(2R)-2-{[(1R)-1-phenyl-3-butenyl]amino}-2-phenyl ethane nitrile 
(4.5): (orange oil, 95 % yield). 1H-NMR (300MHz, CDCl3): δ = 
2.27–2.51 (m, 2H), 2.92 (brs, 1H), 4.06 (dd, J = 8.42, J = 4.76 Hz, 
1H), 4.35 (s, 1H), 4.98–5.10 (m, 2H), 5.66–5.78 (m, 1H), 6.95–7.43 
(m, 10H) ppm. 13C-NMR (50MHz, CDCl3): δ = 42.84 (t), 51.93 (d), 
60.41 (d), 118.56 (t), 118.64 (s), 126.96 (d), 127.24 (d), 127.82 (d), 
128.48 (d), 128.74 (d), 130.24 (d), 134.24 (d), 134.89 (s), 141.36 (s) 















Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
(2R)-2-{[(1R)-1-(2-chlorophenyl)-3-butenyl]amino}-2-phenyl 
ethanenitrile (4.6): (orange oil, 87 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.16–2.60 (m, 2H), 2.82 (brs, 1H), 4.26 (t, J = 7.69 Hz, 
1H), 4.66 (s, 1H), 4.95–5.12 (m, 2H), 5.70–5.83 (m, 1H), 7.11–7.73 
(m, 9H) ppm. 13C-NMR (50MHz, CDCl3): δ = 41.16 (t), 52.10 (d), 
56.08 (d), 117.48 (s), 118.87 (s), 119.03 (t), 127.04 (d), 127.28 (d), 
127.62 (d), 128.29 (d), 128.66 (d), 128.92 (d), 129.99 (d), 134.13 (d), 









ethanenitrile (4.7): (orange oil, 87 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.01 (brs, 1H), 2.29–2.51 (m, 2H), 4.06 (dd, J = 8.61, J 
= 4.94 Hz, 1H), 4.37 (s, 1H), 5.04–5.12 (m, 2H), 5.65–5.79 (m, 1H), 
7.18–7.44 (m, 9H) ppm. 13C-NMR (50MHz, CDCl3): δ = 42.79 (t), 
52.08 (d), 60.09 (d), 118.50 (s), 119.08 (t), 125.62 (d), 127.03 (d), 
127.40 (d), 128.11 (d), 128.90 (d), 128.95 (d), 130.08 (d), 133.89 (d), 
134.65 (s), 134.71 (s), 143.76 (s) ppm. MS (CI): m/z = 297 (100.0) 









ethanenitrile (4.8): (orange oil, 99 % yield). 1H-NMR 
(300MHz, CDCl3): δ = 2.34–2.46 (m, 2H), 2.90 (brs, 1H), 4.04 
(dd, J = 8.24, J = 5.31 Hz, 1H), 4.31 (s, 1H), 4.96–5.01 (m, 2H), 
5.61–5.75 (m, 1H), 6.93–7.10 (m, 1H), 7.19–7.38 (m, 8H) ppm. 
13C-NMR (50MHz, CDCl3): δ = 42.75 (t), 51.94 (d), 59.84 (d), 
118.47 (s), 118.94 (t), 126.96 (d), 128.65 (d), 128.83 (d), 128.92 
(d), 133.43 (s), 133.92 (d), 134.62 (s), 139.94 (s) ppm. MS (CI): m/z = 297 (56.9) [M + H+], 









ethanenitrile (4.9): (orange oil, 81 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.10–2.65 (m, 2H), 4.36 (s, 1H), 4.61 (dd, J = 9.15, J = 
4.02 Hz, 1H), 4.99–5.21 (m, 1H), 5.52–5.63 (m, 2H), 6.68 (d, J = 
8.06 Hz, 2H), 6.88 (d, J = 8.42 Hz, 2H), 7.00–7.60 (m, 5H) ppm. 13C-
NMR (50MHz, CDCl3): δ = 41.18 (t), 51.96 (d), 59.64 (d), 119.00 
(t), 119.16 (s), 124.62 (s), 126.96 (d), 127.86 (d), 128.37 (d), 128.84 
(d), 129.88 (d), 130.11 (s), 131.89 (d), 133.62 (d), 140.17 (s) ppm. MS (CI): m/z = 341 




















ethanenitrile (4.10): (orange oil, 92 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 1.97 (brs, 1H), 2.23–2.49 (m, 2H), 4.03 (dd, J = 8.79, J 
= 4.76 Hz, 1H), 4.35 (s, 1H), 4.98–5.13 (m, 2H), 5.62–5.76 (m, 1H), 
6.93–7.43 (m, 8H), 7.58 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ 
= 35.76 (t), 42.84 (t), 52.11 (d), 60.06 (d), 119.15 (s), 122.97 (s), 
126.09 (d), 127.05 (d), 128.42 (d), 128.97 (d), 130.14 (d), 130.41 (d), 
131.16 (d), 133.91 (d), 134.57 (s), 144.07 (s) ppm. MS (CI): m/z = 









ethanenitrile (4.11): (yellow oil, 83 % yield). 1H-NMR 
(300MHz, CDCl3): δ = 1.97 (brs, 1H), 2.32–2.40 (m, 2H), 2.42–
2.50 (m, 2H), 4.04 (dd, J = 8.79, J = 5.13 Hz, 1H), 4.33 (s, 1H), 
4.98–5.10 (m, 2H), 5.63–5.77 (m, 1H), 7.21–7.42 (m, 7H), 7.47 
(d, J = 8.42 Hz, 2H) ppm. 13C-NMR (50MHz, CDCl3): δ = 42.84 
(t), 52.10 (d), 57.34 (d), 97.96 (t), 119.08 (s), 127.07 (d), 128.95 
(d), 129.00 (d), 129.11 (d), 132.01 (d), 133.98 (d), 137.86 (s), 137.97 (s), 150.99 (d), 









ethanenitrile (4.12): (red oil, 78 % yield). 1H-NMR (300MHz, 
CDCl3) δ = 2.12–2.42 (m, 2H), 4.26 (dd, J = 6.95, J = 4.03 Hz, 1H), 
4.43 (s, 1H), 4.89–5.00 (m, 2H), 5.47–5.61 (m, 1H), 7.16–7.43 (m, 
14H) ppm. 13C-NMR (50MHz, CDCl3) δ = 42.55 (q), 51.62 (d), 
55.39 (d), 118.54 (s), 118.89 (s), 125.93 (d), 127.02 (d), 127.24 (d), 
127.99 (d), 128.15 (d), 128.77 (d), 129.31 (d), 129.85 (d), 130.04 
(d), 130.24 (d), 135.16 (s), 139.04 (s), 140.38 (s), 142.78 (s) ppm. 







ethanenitrile (4.13): (orange oil, 78 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.32–2.54 (m, 2H), 4.14 (dd, J = 8.43, J = 5.12 Hz, 1H), 
4.42 (s, 1H), 5.00–5.18 (m, 2H), 5.68–5.81 (m, 1H), 7.29–7.49 (m, 
11H), 7.56 (d, J = 8.06 Hz, 2H), 7.65 (s, 1H) ppm. 13C-NMR 
(50MHz, CDCl3): δ = 42.71 (t), 51.89 (d), 60.43 (d), 118.51 (t), 
125.85 (d), 125.98 (d), 126.47 (d), 126.85 (d), 127.19 (d), 128.56 (d), 
128.63 (d), 129.08 (d), 134.20 (d), 134.76 (s), 140.52 (s), 141.44 (s), 
















Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
(2R)-2-{[(1R)-1-[1,1'-biphenyl]-4-yl-3-butenyl] amino}-2-
phenyl ethanenitrile (4.18): (orange oil, 80 % yield). 1H-
NMR (300MHz, [D6]DMSO): δ = 2.83–3.16 (m, 2H), 3.41 
(brs, 1H), 4.00 (t, J = 6.60 Hz, 1H), 4.49 (s, 1H), 4.97–5.08 
(m, 2H), 5.58–5.79 (m, 1H), 7.12–7.49 (m, 10H), 7.60–7.70 
(m, 4H) ppm. 13C-NMR (50MHz, [D6]DMSO): δ = 34.30 
(t), 50.04 (d), 59.61 (d), 117.38 (s), 119.35 (s), 126.59 (d), 
126.82 (d), 127.28 (d), 128.51 (d), 128.66 (d), 128.91 (d), 
128.97 (d), 129.76 (d), 131.08 (s), 134.90 (d), 135.70 (s), 








ethanenitrile (4.21): (orange oil, 80 % yield). 1H-NMR (300MHz, 
[D6]DMSO) δ = 2.71–3.02 (m + brs, 3H) 4.67 (s, 1H), 4.98–5.20 
(m + t, 3H), 5.80–5.94 (m, 1H), 7.34–7.56 (m, 8H), 7.78–7.89 (m, 
4H) ppm. 13C-NMR (50MHz, [D6]DMSO) δ = 52.18 (d), 77.42 (t), 
125.54 (d), 125.65 (d), 126.12 (d), 127.04 (d), 128.26 (d), 128.42 
(d), 128.82 (d), 128.97 (d), 131.43 (s), 134.11 (s), 134.58 (d), 







ethanenitrile (4.22): (orange oil, 80 % yield). 1H-NMR 
(300MHz, CDCl3) δ = 2.43–2.64 (m, 2H), 2.87 (brs, 1H), 4.26 
(dd, J = 8.09, J = 4.94 Hz, 1H), 4.38 (s, 1H), 5.03–5.15 (m, 2H), 
5.70–5.84 (m, 1H), 7.23–7.87 (m, 12H) ppm. 13C-NMR 
(50MHz, CDCl3) δ = 42.66 (t), 52.11 (d), 60.74 (d), 118.72 (t), 
124.61 (d), 125.97 (d), 126.32 (d), 126.86 (d), 127.06 (d), 
127.58 (d), 127.64 (d), 127.80 (d), 128.81 (d), 128.85 (d), 
133.24 (s), 133.28 (s), 134.36 (d), 134.97 (s), 138.78 (s) ppm. 






Typical procedure for the retro-Strecker formation of the benzylidene protected 
amines 4.23–4.34. Nitrile 4.5–4.22 (32.5 mmol) was dissolved in ethanol (150 mL). After 
the addition of K2CO3 (2 equiv.; 64.9 mmol; 8.97 gram), the reaction mixture was refluxed 
for two hours. After cooling the reaction mixture to room temperature, the solvent was 
evaporated. The residue was mixed with water (100 mL) and dichloromethane (100 mL). 
The organic phase was separated, dried over Na2SO4 and filtered. Removal of the solvent 















(orange oil, 86 % yield). 1H-NMR (300MHz, CDCl3): δ = 2.67 (t, J = 
6.95 Hz, 2H), 4.32 (t, J = 6.95 Hz, 1H), 4.96–5.14 (m, 2H), 5.61–5.77 
(m, 1H), 7.21–7.43 (m, 8H), 7.75 (dd, J = 6.59, J = 3.30 Hz, 2H), 8.27 
(s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 43.10 (d), 75.26 (d), 
117.12 (t), 126.92 (d), 127.00 (d), 128.33 (d), 128.43 (d), 130.50 (d), 
135.38 (d), 136.22 (s), 143.75 (s), 159.95 (d) ppm. MS (CI): m/z = 236 






amine (4.24): (orange oil, 78 % yield). 1H-NMR (300MHz, CDCl3): δ 
= 2.56–2.70 (m, 2H), 4.83 (t, J = 6.96 Hz, 1H), 4.98–5.09 (m, 2H), 
5.66–5.80 (m, 1H), 7.13–7.37 (m, 7H), 7.72–7.81 (m, 2H), 8.30 (s, 
1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 41.72 (t), 70.43 (d), 117.48 
(t), 126.91 (d), 128.29 (d), 127.80 (d), 128.47 (d), 128.82 (d), 129.31 
(d), 130.63 (d), 132.37 (s), 134.96 (d), 136.14 (s), 141.15 (s), 160.88 







amine (4.25): (orange oil, 85 % yield). 1H-NMR (300MHz, CDCl3): δ 
= 2.61 (t, J = 6.96 Hz, 2H), 4.26 (t, J = 6.96 Hz, 1H), 4.96–5.02 (m, 
2H), 5.58–5.72 (m, 1H), 7.15–7.42 (m, 7H), 7.74 (dd, J = 5.85, J = 
2.19 Hz, 2H), 8.24 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 43.15 
(t), 74.69 (d), 117.57 (t), 120.12 (s), 125.50 (d), 127.07 (d), 127.20 (d), 
128.32 (d), 128.51 (d), 129.58 (d), 130.73 (d), 134.15 (s), 134.84 (d), 
145.86 (s), 160.41 (d) ppm. MS (CI): m/z = 270 (100.0) [M + H+], 272 







1-amine (4.26): (orange oil, 86 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.61 (dt, J = 6.96 Hz, 2H), 4.28 (t, J = 6.96 Hz, 1H), 
4.96–5.05 (m, 2H), 5.56–5.73 (m, 1H), 7.26 (d, J = 8.42 Hz, 2H), 
7.34–7.36 (m, 5H), 7.72–7.75 (m, 2H), 8.25 (s, 1H) ppm. 13C-
NMR (50MHz, CDCl3): δ = 43.13 (t), 74.43 (d), 117.47 (t), 
128.13 (d), 128.22 (d), 128.34 (d), 128.40 (d), 128.45 (d), 130.63 
(d), 132.48 (s), 134.86 (d), 136.02 (s), 142.24 (s), 160.17 (d) ppm. MS (CI): m/z = 270 
















Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
(1R)-1-(2-bromophenyl)-N-[(E)-phenylmethylidene]-3-buten-1-
amine (4.27): (orange oil, 75 % yield). 1H-NMR (300MHz, CDCl3): δ 
= 2.47–2.69 (m, 2H), 4.77 (dd, J = 8.2, J = 4.6 Hz, 1H), 4.97–5.10 (m, 
2H), 5.62–5.80 (m, 1H), 6.94–7.50 (m, 6H), 7.73–7.76 (m, 2H), 8.29 
(s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 41.67 (t), 72.85 (d), 
117.53 (t), 126.39 (d), 127.49 (s), 127.52 (d), 128.05 (d), 128.25 (d), 
128.27 (d), 129.75 (d), 130.63 (d), 133.15 (d), 131.71 (d), 142.68 (s), 







amine (4.28): (orange oil, >99 % yield). 1H-NMR (300MHz, CDCl3): 
δ = 2.94 (t, J = 7.08 Hz, 2H), 4.30 (t, J = 6.83 Hz, 1H), 4.99–5.22 (m, 
2H), 5.44–5.84 (m, 1H), 7.00–7.45 (m, 8H), 7.70–7.81 (m, 1H), 8.23 
(s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 36.10 (t), 74.64 (d), 
117.60 (d), 118.24 (s), 118.67 (s), 125.65 (d), 128.16 (d), 128.31 (d), 
129.99 (d), 130.12 (d), 130.43 (d), 130.72 (d), 134.80 (d), 146.23 (s), 








1-amine (4.29) : (red oil, >99 % yield). 1H-NMR (300MHz, 
CDCl3): δ = 2.64 (t, J = 6.84 Hz, 2H), 4.30 (t, J = 6.96 Hz, 1H), 
4.98–5.16 (m, 2H), 5.79–5.44 (m, 1H), 7.45–7.29 (m, 7H), 7.77 
(dd, J = 6.11, J = 2.44 Hz, 2H), 8.29 (s, 1H) ppm. 13C-NMR 
(50MHz, CDCl3): δ = 43.13 (t), 74.53 (d), 117.51 (t), 124.79 (d), 
126.65 (s), 128.16 (d), 128.26 (d), 128.48 (d), 128.66 (d), 128.76 
(d), 130.04 (d), 130.67 (d), 131.38 (d), 136.04 (d), 160.23 (d) ppm. MS (CI): m/z = 314 







1-amine (4.30): (red oil, 70 % yield). 1H-NMR (300MHz, CDCl3) δ 
= 2.64 (t, J = 6.59 Hz, 1H), 4.55 (t, J = 6.59 Hz, 1H), 4.90–4.94 (m, 
2H), 5.52–5.66 (m, 1H), 7.20–7.45 (m, 11H), 7.70–7.73 (m, 2H), 
7.87 (d, J = 8.06 Hz, 1H), 7.98 (s, 1H) ppm. 13C-NMR (50MHz, 
CDCl3) δ = 42.58 (t), 70.40 (d), 116.98 (t), 126.31 (d), 126.86 (d), 
127.50 (d), 127.66 (d), 127.95 (d), 128.13 (d), 128.34 (d), 129.40 (d), 
129.83 (d), 130.38 (d), 135.26 (d), 136.25 (s), 140.81 (s), 141.04 (s), 

















amine (4.31): (red oil, 69 % yield). 1H-NMR (300MHz, CDCl3): δ = 
2.81 (t, J = 6.78 Hz, 2H), 4.46 (t, J = 7.69 Hz, 1H), 5.07–5.15 (m, 2H), 
5.74–5.88 (m, 1H), 7.37–7.52 (m, 9H), 7.67 (d, J = 7.69 Hz, 2H), 7.76 
(s, 1H), 7.81–7.88 (m, 2H), 8.37 (s, 1H) ppm. 13C-NMR (50MHz, 
CDCl3) δ = 43.16 (t), 75.34 (d), 117.22 (t), 125.76 (d), 125.84 (d), 
125.97 (d), 127.12 (d), 128.24 (d), 128.40 (d), 128.61 (d), 128.74 (d), 
130.49 (d), 135.26 (d), 136.14 (s), 141.11 (s), 141.20 (s), 144.28 (s), 






buten-1-amine (4.32): (red oil, 79 % yield). 1H-NMR 
(300MHz, CDCl3): δ = 2.86–3.05 (m, 2H), 4.39 (t, J = 6.8 
Hz, 1H), 5.02–5.14 (m, 2H), 5.53–5.69 (m, 1H), 7.06–7.59 
(m, 12H), 7.78–7.81 (m, 2H), 8.32 (s, 1H) ppm. 13C-NMR 
(50MHz, CDCl3): δ = 43.02 (t), 56.68 (d), 117.20 (t), 126.80 
(d), 126.93 (d), 127.04 (d), 127.24 (d), 127.37 (d), 128.03 
(d), 128.21 (d), 128.34 (d), 128.75 (d), 131.67 (s), 139.44 (s), 
139.94 (s), 154.78 (s), 159.99 (d) ppm. MS (CI): m/z = 312 






(4.39): (green oil, 95 % yield). 1H-NMR (300MHz, CDCl3) δ = 2.89 
(t, J = 6.59 Hz, 2H), 5.04–5.13 (m, 2H), 5.19 (t, J = 7.14 Hz, 1H), 
5.78–5.92 (m, 1H), 7.39–7.58 (m, 6H), 7.75–7.89 (m, 5H), 8.32 (d, J 
= 8.42 Hz, 1H), 8.39 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3) δ = 
42.51 (t), 71.22 (d), 117.08 (t), 123.45 (d), 124.65 (d), 125.28 (d), 
125.56 (d), 125.80 (d), 127.39 (d), 128.29 (d), 128.45 (d), 128.94 (d), 
130.54 (d), 130.64 (s), 133.97 (s), 135.67 (d), 136.30 (s), 139.75 (s), 






amine (4.40): (red oil, 94 % yield). 1H-NMR (300MHz, CDCl3) 
δ = 2.77 (t, J = 6.96 Hz, 2H), 4.50 (t, J = 6.96 Hz, 1H), 4.98–5.08 
(m, 2H), 5.61–5.81 (m, 1H), 7.31–7.48 (m, 5H), 7.60 (d, J = 8.42 
Hz, 1H), 7.78–7.84 (m, 6H), 8.34 (s, 1H) ppm. 13C-NMR 
(50MHz, CDCl3) δ = 43.05 (t), 75.33 (d), 117.24 (t), 125.51 (d), 
125.88 (d), 127.60 (d), 127.86 (d), 128.05 (d), 128.31 (d), 128.49 
(d), 130.10 (d), 132.71 (s), 135.34 (d), 136.29 (s), 141.22 (s), 













Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
Hydrolysis of the N-benzylidene protected homoallylamines 4.23–4.40. N-benzylidene 
4.23–4.40 (9.94 mmol) was dissolved in a 50 % aqueous THF (100 mL) solution. 
Hydroxylamine hydrochloride (NH2OH·HCl, 2.08 gram, 29.8 mmol, 3 equiv.) was added 
and the reaction mixture was stirred overnight at ambient temperature. The THF was 
evaporated under reduced pressure and the residue was brought to pH 1 with aqueous HCl 
(30 %). The aqueous phase was washed once with dichloromethane to remove by-products. 
The aqueous phase was adjusted to pH 10 with aqueous NaOH (33 %) and extracted with 
dichloromethane. After drying over Na2SO4, the solvent was evaporated to furnish the (R)-
arylbutenylamine as an oily material. If necessary, the 1-aryl-3-butenylamines can be 
purified by Kugelrohr distillation. 
 
(1R)-1-phenyl-3-butenylamine (4.41): (yellow oil, 80 % yield). 1H-
NMR (300MHz, CDCl3): δ = 1.57 (brs, 2H), 2.26–2.46 (m, 2H), 3.94 
(dd, J = 7.87, J = 5.31 Hz, 1H), 5.01–5.09 (m, 2H), 5.63–5.77 (m, 
1H), 7.29–7.19 (m, 5H) ppm. 13C-NMR (50MHz, CDCl3): δ = 44.00 
(t), 55.19 (d), 117.41 (t), 126.12 (d), 126.77 (d), 128.11 (d), 135.26 




(1R)-1-(2-chlorophenyl)-3-butenylamine (4.42): (yellow oil, 75 % 
yield, >99:1 er). [α]D25 = +61.0 (c = 3.44, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 1.48 (brs, 2H), 2.17–2.27 (m, 1H), 2.42–2.52 (m, 1H), 
4.39 (dd, J = 8.24, J = 4.58 Hz, 1H), 4.97–5.09 (m, 2H), 5.63–5.79 (m, 
1H), 7.08 (dt, J = 7.69, J = 1.09 Hz, 1H), 7.17 (d, J = 7.69 Hz, 1H), 
7.24 (t, J = 8.79 Hz, 1H), 7.44 (dd, J = 7.69, J = 1.09 Hz, 1H) ppm. 13C-NMR (50MHz, 
CDCl3): δ = 41.91 (t), 51.04 (d), 117.72 (t), 126.82 (d), 127.03 (d), 127.71 (d), 129.34 (d), 
132.55 (s), 134.98 (d), 142.71 (s) ppm. MS (CI): m/z = 182 (100.0) [M + H+], 184 (33.1) 





(1R)-1-(3-chlorophenyl)-3-butenylamine (4.43): (yellow oil, 58 % 
yield, >99:1 er). [α]D25 = +31.5 (c = 2.98, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 1.55 (brs, 2H), 2.21–2.42 (m, 2H), 3.91 (dd, J = 7.87, J = 
5.13 Hz, 1H), 5.02–5.08 (m, 2H), 5.59–5.73 (m, 1H), 7.12–7.22 (m, 
3H), 7.29 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 43.87 (t), 
54.73 (d), 117.85 (d), 124.41 (d), 126.37 (d), 127.01 (d), 129.47 (d), 
134.02 (s), 134.72 (d), 147.80 (s) ppm. MS (CI): m/z = 182 (100.0) [M + H+], 184 (34.3) 
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(1R)-1-(4-chlorophenyl)-3-butenylamine (4.44): (orange oil, 70 
% yield, >99:1 er). [α]D25 = +30.0 (c = 2.99, CHCl3). 1H-NMR 
(300MHz, CDCl3): δ = 1.59 (brs, 2H), 2.18–2.37 (m, 2H), 3.88 
(dd, J = 7.69, J = 5.50 Hz, 1H), 4.98–5.05 (m, 2H), 5.56–5.70 (m, 
1H), 7.16–7.27 (m, 4H) ppm. 13C-NMR (50MHz, CDCl3): δ = 
43.91 (t), 54.51 (d), 117.75 (t), 127.56 (d), 128.24 (d), 132.25 (s), 134.76 (d), 144.00 (s) 





(1R)-1-(2-bromophenyl)-3-butenylamine (4.45): (red oil, 65 % 
yield, >99:1 er). [α]D25 = +39.3 (c = 2.40, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 1.49 (brs, 2H), 2.13–2.23 (m, 1H), 2.42–2.50 (m, 1H), 
4.34 (dd, J = 8.42, J = 4.40 Hz, 1H), 4.97–5.09 (m, 2H), 5.65–5.70 (m, 
1H), 7.00 (t, J = 7.69 Hz, 1H), 7.22 (t, J = 7.69 Hz, 1H), 7.44 (d, J = 
8.06 Hz, 2H) ppm. 13C-NMR (50MHz, CDCl3): δ = 41.98 (t), 53.41 (d), 117.74 (t), 123.06 
(s), 127.24 (d), 127.43 (d), 128.09 (d), 132.59 (d), 134.91 (d), 144.20 (s) ppm. MS (CI): m/z 





(1R)-1-(3-bromophenyl)-3-butenylamine (4.46): (yellow oil, 51 % 
yield, >99:1 er). [α]D25 = +29.9 (c = 2.84, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 1.87 (brs, 2H), 2.12–2.42 (m, 2H), 3.90 (dd, J = 7.69, J = 
5.49 Hz, 1H), 4.97–5.08 (m, 2H), 5.59–5.72 (m, 1H), 7.12 (t, J = 7.69 
Hz, 1H), 7.20 (d, J = 7.69 Hz, 1H), 7.30 (d, J = 7.69 Hz, 1H), 7.44 (s, 
1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 43.89 (t), 54.83 (d), 117.75 
(t), 118.06 (t), 122.46 (s), 125.00 (d), 129.44 (d), 129.91 (d), 129.99 (d), 134.73 (d), 147.95 





(1R)-1-(4-bromophenyl)-3-butenylamine (4.47): (pale yellow 
oil, 48 % yield, >99:1 er). 1H-NMR (300MHz, CDCl3): δ = 1.61 
(brs, 2H), 2.12–2.41 (m, 2H), 3.92 (t, J = 6.37 Hz, 1H), 5.02–5.08 
(m, 2H), 5.59–5.73 (m, 1H), 7.17 (d, J = 8.42 Hz, 2H), 7.39 (d, J 
= 8.42 Hz, 2H) ppm. 13C-NMR (50MHz, CDCl3): δ = 44.05 (t), 
54.77 (d), 118.01 (t), 120.60 (s), 128.11 (d), 131.43 (d), 134.87 (d), 150.98 (s) ppm. MS 





(1R)-1-[1,1'-biphenyl]-2-yl-3-butenylamine (4.48): (yellow oil, 57 
% yield). 1H-NMR (300MHz, CDCl3): δ = 2.20–2.40 (m + brs, 4H), 
3.98 (t, J = 4.22 Hz, 1H), 4.94–5.03 (m, 2H), 5.56–5.73 (m, 1H), 
7.05–7.34 (m, 9H) ppm. 13C-NMR (50MHz, CDCl3): δ = 44.52 (t), 












Non-reductive Removal of the (R)-Phenylglycine Amide Chiral Auxiliary 
130.03 (d), 130.22 (d), 133.33 (d), 135.28 (s), 145.79 (s), 148.22 (s). MS (CI): m/z = 224 
[M + H+]. 
 
(1R)-1-[1,1'-biphenyl]-3-yl-3-butenylamine (4.49): (yellow oil, 45 
% yield). [α]D25 = +12.5 (c = 0.98, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 1.96 (brs, 1H), 2.28–2.47 (m, 2H), 3.99 (t, J = 6.41 Hz, 
1H), 5.01–5.20 (m, 2H), 5.65–5.78 (m, 1H), 7.24–7.42 (m, 6H), 7.52–
7.55 (m, 3H) ppm. 13C-NMR (50MHz, CDCl3): δ = 44.00 (t), 55.22 
(d), 117.51 (t), 124.99 (d), 125.10 (d), 125.57 (d), 126.94 (d), 127.04 
(d), 128.50 (d), 128.61 (d), 135.17 (d), 140.96 (s), 141.07 (s),      




(1R)-1-[1,1'-biphenyl]-4-yl-3-butenylamine (4.50): (yellow 
oil, 49 % yield). 1H-NMR (300MHz, CDCl3): δ = 1.85 (brs, 
2H), 2.28–2.51 (m, 1H), 2.81–3.00 (m, 1H), 4.00 (t, J = 5.86 
Hz, 1H), 4.98–5.13 (m, 2H), 5.50–5.80 (m, 1H), 7.09–7.46 
(m, 7H), 7.53 (t, J = 7.32 Hz, 2H) ppm. 13C-NMR (50MHz, 
CDCl3) δ = 40.02 (t), 55.05 (d), 117.77 (t), 126.93 (d), 
127.00 (d), 128.09 (d), 128.70 (d), 130.10 (d), 131.14 (s), 




(1R)-1-(1-naphthyl)-3-butenylamine (4.51): (yellow oil, 60 % 
yield). 1H-NMR (300MHz, CDCl3) δ = 1.65 (brs, 2H), 2.38–2.48 (m, 
2H), 4.82 (dd, J = 7.51, J = 3.85 Hz, 1H), 5.10–5.20 (m, 2H), 5.77–
5.91 (m, 1H), 7.43–7.52 (m, 3H), 7.63 (d, J = 6.96 Hz, 1H), 7.73 (d, 
J = 8.05 Hz, 1H), 7.84 (d, J = 7.69 Hz, 1H), 8.11 (d, J = 7.69 Hz, 
1H) ppm. 13C-NMR (50MHz, CDCl3) δ = 43.00 (t), 50.17 (d), 
117.57 (t), 122.35 (d), 122.69 (d), 125.26 (d), 125.38 (d), 125.81 (d), 
127.22 (d), 128.85 (d), 130.67 (s), 133.74 (s), 135.46 (d), 141.28 (s) ppm. MS (CI): m/z = 




(1R)-1-(2-naphthyl)-3-butenylamine (4.52): (yellow oil, 47 % 
yield). 1H-NMR (300MHz, CDCl3) δ = 1.68 (brs, 2H), 2.35-2.55 
(m, 2H), 4.10 (t, J = 6.59 Hz, 1H), 5.66–5.80 (m, 2H), 7.38–7.44 
(m, 3H), 7.73–7.79 (m, 4H) ppm. 13C-NMR (50MHz, CDCl3) δ = 
43.89 (t), 55.28 (d), 117.58 (t), 124.54 (d), 124.73 (d), 125.39 (d), 
125.87 (d), 127.48 (d), 127.66 (d), 127.97 (d), 132.58 (s), 133.28 
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Typical procedure for the catalytic hydrogenation of 1-aryl-3-butenylamines (R)-4.41–
4.52. The 1-aryl-3-butenylamine 4.41–4.52 (15.0 mmol) was dissolved in EtOAc (100 mL), 
and Pt–C (5 %) (0.6 gram, cat.) was added successively. After two vacuum/H2 cycles to 
remove air from the reaction flask, the stirred mixture of the substrate was hydrogenated at 
ambient pressure of H2 and room temperature for 1 hour. The catalyst was removed by 
filtration over Celite. The filtrate was concentrated in vacuo to give the arylbutylamine as 
an oil. 
 
(1R)-1-(2-chlorophenyl)butylamine (4.53): (green oil, 91 % yield, 
>99:1 er). 1H-NMR (300MHz, CDCl3): δ = 0.87 (t, J = 7.33 Hz, 3H), 
1.21–1.43 (m, 2H), 1.57–1.72 (m, 2H), 1.90 (brs, 2H), 4.34 (t, J = 6.60 
Hz, 1H), 7.09 (t, J = 7.69 Hz, 1H), 7.19 (d, J = 7.69 Hz, 1H), 7.25 (t, J 
= 8.24 Hz, 1H), 7.41 (d, J = 7.30 Hz, 1H) ppm. 13C-NMR (50MHz, 
CDCl3) δ = 13.71 (q), 19.32 (t), 39.85 (t), 51.37 (d), 126.80 (d), 127.46 (d), 129.21 (d), 





(1R)-1-(3-chlorophenyl)butylamine (4.54): (orange oil, >99 % yield, 
>99:1 er). [α]D25 = +24.2 (c = 3.14, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 0.83 (t, J = 7.33 Hz, 3H), 1.09–1.33 (m, 2H), 1.46–1.61 
(m, 2H), 1.65 (brs, 2H), 3.79 (t, J = 6.59 Hz, 1H), 7.09–7.20 (m, 3H), 
7.24 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.85 (q), 19.48 (t), 
41.61 (t), 55.51 (d), 124.47 (d), 126.41 (d), 126.82 (d), 129.53 (d), 





(1R)-1-(4-chlorophenyl)butylamine (4.55): (yellow oil, >99 % 
yield, >99:1 er). [α]D25 = +11.2 (c = 6.35, CHCl3). 1H-NMR 
(300MHz, CDCl3): δ = 0.83 (t, J = 7.14 Hz, 3H), 1.15–1.32 (m, 
2H), 1.49–1.64 (m, 2H), 2.11 (brs, 2H), 3.83 (t, J = 6.77 Hz, 1H), 
7.19 (d, J = 8.42 Hz, 2H), 7.23 (d, J = 8.42 Hz, 2H) ppm. 13C-
NMR (50MHz, CDCl3): δ = 13.68 (q), 19.29 (t), 41.41 (t), 55.06 (d), 127.49 (d), 128.14 (d), 





(1R)-1-(2-bromophenyl)butylamine (4.56): (dark green oil, 99 % 
yield, >99:1 er). [α]D25 = +17.9 (c = 3.33, CHCl3). 1H-NMR (300MHz, 
CDCl3): δ = 0.86 (t, J = 7.33 Hz, 3H), 1.16–1.38 (m, 2H), 1.46–1.70 
(m, 2H), 2.00 (brs, 2H), 4.28 (t, J = 6.78 Hz, 1H), 7.00 (dt, J = 7.69, J 
= 1.46 Hz, 1H), 7.23 (t, J = 7.69 Hz, 1H), 7.39 (dd, J = 7.69, J = 1.46 
Hz, 1H), 7.44 (dd, J = 7.69, J = 1.46 Hz, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.76 
(q), 19.32 (t), 39.91 (t), 53.81 (d), 123.19 (s), 127.03 (d), 127.48 (d), 127.92 (d), 132.51 (d), 
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(1R)-1-(3-bromophenyl)butylamine (4.57): (orange oil, >99 % yield, 
>99:1 er). 1H-NMR (300MHz, CDCl3): δ = 0.82 (t, J = 7.32 Hz, 3H), 
1.08–1.31 (m, 2H), 1.49–1.63 (m, 2H), 2.56 (brs, 2H), 3.78 (t, J = 6.96 
Hz), 7.10 (t, J = 7.69 Hz, 1H), 7.15 (d, J = 7.69 Hz, 1H), 7.28 (d, J = 
7.69 Hz, 1H), 7.40 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 
13.85 (q), 19.48 (t), 41.61 (t), 55.51 (d), 124.47 (d), 126.41 (d), 126.82 
(d), 129.53 (d), 134.08 (s), 148.79 (s) ppm. MS (CI): m/z = 228 (100.0) [M + H+],           





(1R)-1-(4-bromophenyl)butylamine (4.58): (yellow oil, 85 % 
yield, >99:1 er). 1H-NMR (300MHz, CDCl3): δ = 0.81 (t, J = 7.32 
Hz, 3H), 1.04–1.33 (m, 2H), 1.43–1.56 (m + brs, 4H), 3.78 (t, J = 
6.78 Hz, 1H), 7.15 (d, J = 8.06 Hz, 2H), 7.35 (d, J = 8.06 Hz, 2H) 
ppm. 13C-NMR (50MHz, CDCl3): δ = 13.84 (q), 19.44 (t), 41.62 
(t), 55.27 (d), 120.23 (s), 128.22 (d), 131.25 (d), 150.85 (s) ppm. MS (CI): m/z = 228 (95.8) 





(1R)-1-[1,1'-biphenyl]-3-ylbutylamine (4.59): (pale green oil, 93 % 
yield). 1H-NMR (300MHz, CDCl3): δ = 0.88 (t, J = 7.33 Hz, 3H), 
1.15–1.41 (m, 2H), 1.61–1.73 (m, 2H), 2.14 (brs, 2H), 3.92 (t, J = 6.96 
Hz, 1H), 7.25–7.45 (m, 6H), 7.51 (s, 1H), 7.59 (d, J = 6.95 Hz, 2H) 
ppm. 13C-NMR (50MHz, CDCl3): δ = 11.56 (q), 17.27 (t), 39.27 (t), 
53.64 (d), 122.79 (d), 122.82 (d), 123.28 (d), 124.72 (d), 124.78 (d), 
126.24 (d), 126.39 (d), 138.77 (s), 138.88 (s), 144.54 (s) ppm.         




(1R)-1-[1,1'-biphenyl]-4-ylbutylamine (4.60): (orange oil, 
95 % yield). 1H-NMR (300MHz, CDCl3): δ = 0.82 (t, J = 
7.32 Hz, 3H), 1.20–1.41 (m, 2H), 1.55–1.68 (m + brs, 4H), 
3.89 (t, J = 6.96 Hz, 1H), 7.27–7.41 (m, 7H), 7.54 (t, J = 8.42 
Hz, 2H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.77 (q), 
19.44 (t), 41.54 (t), 55.36 (d), 126.46 (d), 126.65 (d), 126.77 
(d), 128.42 (d), 139.34 (s), 140.60 (s), 145.59 (s) ppm.       




(1R)-1-(1-naphthyl)butylamine (4.61):  (yellow oil, >99 % yield). 
1H-NMR (300MHz, CDCl3) δ = 0.90 (t, J = 7.33 Hz, 1H), 1.31–1.49 
(m, 2H), 1.65–1.89 (m + brs, 4H), 4.73 (t, J = 6.41 Hz, 1H), 7.40–
7.49 (m, 3H), 7.57 (d, J = 7.32 Hz, 1H), 7.69 (d, J = 8.05 Hz, 1H), 
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13C-NMR (50MHz, CDCl3) δ = 14.01 (q), 19.86 (t), 40.95 (t), 50.60 (d), 122.24 (d), 122.80 
(d), 125.26 (d), 125.48 (d), 125.76 (d), 127.08 (d), 128.85 (d), 130.86 (s), 133.78 (s), 142.2 
(s) ppm. MS (CI): m/z = 200 (M + H+). 
 
(1R)-1-(2-naphthyl)butylamine (4.62): (yellow oil, >99 % 
yield). 1H-NMR (300MHz, CDCl3) δ = 0.86 (t, J = 7.32 Hz, 3H), 
1.15–1.39 (m, 2H), 1.42–1.72 (m + brs, 4H), 4.02 (t, J = 6.96 Hz, 
1H), 7.37–7.42 (m, 3H), 7.69 (s, 1H), 7.75–7.80 (m, 3H) ppm. 
13C-NMR (50MHz, CDCl3) δ = 13.82 (q), 19.35 (t), 41.18 (t), 
55.80 (d), 124.53 (d), 124.64 (d), 125.26 (d), 125.75 (d), 127.39 
(d), 127.52 (d), 127.93 (d), 132.48 (s), 133.19 (s), 143.48 (s) ppm. 




Synthesis of the nitro-substituted 1-phenyl-1-butylamines (R)-4.64 and (R)-4.65. 
Enantiomerically pure (R)-1-phenyl-1-butylamine 3.64 (35 mmol, 5.22 gram) was 
cautiously added with continuous stirring during 10 minutes to HNO3 (30 mL) at –5 °C. An 
exothermic reaction proceeded, and the temperature was maintained at –5 °C. The reaction 
was followed by 1H-NMR, and was complete after stirring at –5 °C for 1 hour. The reaction 
mixture was poured on crushed ice (100 gram) and the pH was carefully adjusted to a value 
of 10 with aqueous NaOH (33 %). The aqueous layer was extracted with dichloromethane 
and dried over sodium sulphate. Removal of the solvent provided a mixture of (R)-4.64 and 
(R)-4.65 in a ratio of 22:78 and this mixture of regio-isomers was used without further 
purification. 
  
(1R)-1-(2-nitrophenyl)butylamine (4.64): (yellow oil, 20 % yield). 
1H-NMR (300MHz, CDCl3): δ = 0.86 (t, J = 7.14 Hz, 3H), 1.14–1.36 
(m, 2H), 1.55–1.84 (m, 2H), 1.96 (brs, 2H), 3.99 (t, J = 6.78 Hz, 1H), 
7.40–7.63 (m, 2H), 8.03–8.26 (m, 2H) ppm. 13C-NMR (50MHz, 
CDCl3): δ = 13.75 (q), 19.30 (t), 41.40 (t), 55.28 (d), 121.29 (d), 
121.86 (d), 129.21 (d), 132.74 (d), 146.75 (s), 148.20 (s), 152.97 (s) ppm. MS (CI): m/z = 





(1R)-1-(4-nitrophenyl)butylamine (4.65): (yellow oil, 75 % 
yield). 1H-NMR (300MHz, CDCl3): δ = 0.85 (t, J = 7.14 Hz, 
3H), 1.17–1.34 (m, 2H), 1.47 (brs, 2H), 1.51–1.63 (m, 2H), 3.98 
(t, J = 6.78 Hz, 1H), 7.44 (d, J = 8.79 Hz, 2H), 8.12 (t, J = 8.79 
Hz, 2H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.79 (q), 19.34 
(t), 41.66 (t), 55.40 (d), 123.51 (d), 127.12 (d), 146.15 (s), 154.28 (s) ppm. MS (CI): m/z = 
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Meta-nitrobutyrophenone (4.67):[14] Commercially available 
butyrophenone 4.66 (169 mmol, 25.0 gram) was cautiously added with 
continuous stirring during 30 minutes to HNO3 (150 mL ) at –5 °C. An 
exothermic reaction proceeded, and the temperature was maintained at 
–5 °C. The reaction was followed by 1H-NMR, and was complete after 
stirring at –5 °C for 4 hours. The reaction mixture was poured on 
crushed ice (500 gram), the crude meta-nitro compound precipitated as 
a yellow curdled solid. The yellow solid was removed by filtration under suction and 
subsequently dissolved in diethyl ether (200 mL) and dried over sodium sulphate. After 
filtration and removal of the ether an yellow oil was obtained, from which the crude m-nitro 
compound separated on standing as yellow plates. After removal of the oil, the yellow 
plates were recrystallized once from abs. alcohol. Pure 4.67 was obtained as pale yellow 
plates (92.9 mmol, 18.0 gram, 55 % yield). m.p. 60.4–60.6 °C; lit.[14a] 61°C.                     
1H-NMR (300MHz, CDCl3): δ = 0.91 (t, J = 7.33 Hz, 3H), 1.63–1.75 (m, 2H), 2.92 (t, J = 
7.14 Hz, 2H), 7.59 (dt, J = 8.06 Hz, 1H), 8.19 (d, J = 7.69 Hz, 1H), 8.28 (d, J = 8.06 Hz, 
1H), 8.63 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.56 (q), 17.23 (t), 40.49 (t), 
122.67 (d), 126.99 (d), 129.75 (d), 138.07 (s), 139.46 (d), 148.24 (s), 197.85 (s) ppm. Anal. 
calcd for C10H11NO3: C, 62.17 %; H, 5.74 %; N, 7.25 %. Found: C, 62.15 %; H, 5.68 %; N, 




(±)-1-(3-Nitrophenyl)butylformamide (4.68): A mixture of m-
nitrobutyrophenone 4.67 (129 mmol, 25.0 gram), formamide (77 
mL) and formic acid (35 mL) was heated to reflux. The mixture was 
refluxed for several hours until the reaction was complete (followed 
by 1H-NMR). After cooling to ambient temperature, 200 mL of 
water was added and the mixture was extracted with diethylether     
(3 × 100 mL). The combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated to furnish a red oil (129 mmol, 
28.7 gram, >99 % yield). 1H-NMR (300MHz, CDCl3): δ = 0.80       
(t, J = 7.32 Hz, 3H), 1.11–1.36 (m, 2H), 1.58–1.75 (m, 2H), 4.98 (dd, J = 15.01, J = 7.69 
Hz, 1H), 7.31 (brs, 1H), 7.38 (t, J = 8.06 Hz, 1H), 7.54 (d, J = 7.69 Hz, 1H), 7.97 (d,           
J = 8.06 Hz, 1H), 8.07 (s, 1H), 8.09 (s, 1H) ppm. 13C-NMR (50MHz, CDCl3): δ = 13.35 
(q), 19.05 (t), 37.85 (t), 51.78 (d), 120.97 (d), 122.24 (d), 129.50 (d), 133.06 (d), 144.18 (s), 
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(±)-1-(3-Nitrophenyl)-1-butylamine (4.69): A mixture of (±)–4.68 
(129 mmol, 28.7 gram) and 100 mL aqueous HCl (30 %) was refluxed 
overnight. After cooling to ambient temperature, 200 mL of water was 
added. The reaction mixture was carefully adjusted to pH 10 with 
aqueous NaOH (33 %) and extracted with diethylether (3 × 100 mL). 
The combined organic layers were washed with brine, dried over 




Second Generation Dutch Resolution of 
(±)-4.69: To a solution of the racemic 
substrate (80.00 mmol, 15.54 gram) in 160.0 
mL 2-butanone and 80.0 mL of water was 
added one equivalent of the mixture of 
resolving agents (consisting of 72 mmol   
(+)-4.70 and 8 mmol of (+)-4.73). The 
mixture was heated until a clear solution was obtained. While stirring, the solution was 
allowed to cool to room temperature overnight. The salt was removed by filtration under 
suction and washed with a little i-propanol. The salt obtained was recrystallized once from 
i-propanol/H2O (2:1). 1H-NMR (300MHz, [D6]DMSO): δ = 0.61 (s, 3H), 0.78 (t, J = 7.20 
Hz, 3H), 0.83 (s, 3H), 1.04–1.27 (m, 2H), 1.76–2.01 (m, 2H), 3.23 (dd, 3JP-H = 23.07, 2JAB = 
10.61 Hz, 1H), 3.99 (d, 3JP-H = 10.26 Hz, 1H), 4.38 (dd, J = 8.61, J = 5.68 Hz, 1H), 5.00 (d, 
3JP-H = 2.68 Hz, 1H), 7.24–7.35 (m, 5H), 7.70 (t, J = 8.05 Hz, 1H), 8.00 (d, J = 7.69 Hz, 
1H), 8.23 (d, J = 8.42 Hz, 1H), 8.45 (s, 1H), 8.81 (brs, 3H, NH3+). 13C-NMR (50MHz, 
[D6]DMSO) δ = 12.35 (q), 16.32 (q), 17.26 (t), 19.92 (q), 34.24 (s, 3JC-P = 2.67 Hz), 35.15 
(t), 52.27 (d), 74.36 (t, 2JC-P = 4.96 Hz), 82.43 (d), 121.43 (d), 122.22 (d), 126.16 (d), 
126.24 (d), 126.35 (d), 129.19 (d), 133.30 (d), 137.88 (s, 3JC-P = 11.50 Hz), 139.62 (s), 
146.83 (s). 31P-NMR (81MHz, [D6]DMSO): δ = –5.08. Anal. calcd for              
C10H14N2O2· C11H15O4P: C, 57.79 %; H, 6.70 %; N, 6.42 %. Found: C, 57.57 %; H, 6.90 %; 










The less soluble salt was shown to contain (R)–4.69 of >99 % ee by HPLC analysis.[10] The 
purified salt was treated with 6 M NaOH solution to liberate the free amine (R)–4.69 of   
>99 % ee in 24 % yield starting from (±)–4.69. [α]D25 = –5.4 (c = 2.15, CHCl3). 1H-NMR 
(200MHz, CDCl3): δ = 0.77 (t, J = 7.32 Hz, 3H), 1.04–1.29 (m, 2H), 1.47–1.58 (m + brs, 
4H), 3.91 (t, J = 6.78 Hz, 1H), 7.35 (t, J = 7.69 Hz, 1H), 7.55 (d, J = 7.69 Hz, 1H), 7.92 (d, 
J = 8.06 Hz, 1H), 8.06-8.09 (m, 1H) ppm. 13C-NMR (50MHz,CDCl3): δ = 13.67 (t), 19.23 
(q), 41.57 (t), 55.16 (d), 121.21 (d), 121.58 (d), 129.01 (d), 132.61 (d), 148.06 (s), 148.76 
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X-ray crystallographic data of (S)-4.70/(R)-4.69[18] 
Formula 
Mw (g·mol-1) 














number of reflections 
number of refined parameters 
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